For PAH, Bioelectronic Medicine May Open New Therapy Avenues - Pulmonary Hypertension News

For PAH, Bioelectronic Medicine May Open New Therapy Avenues - Pulmonary Hypertension News

For PAH, Bioelectronic Medicine May Open New Therapy Avenues - Pulmonary Hypertension News

Posted: 13 Dec 2019 12:00 AM PST

Bioelectronic medicine is a promising new therapeutic approach to treat pulmonary arterial hypertension (PAH), according to a recent review study.

The review, "Pulmonary arterial hypertension: the case for a bioelectronic treatment," was published in the journal Bioelectronic Medicine.

Current treatments for PAH include medications that interfere with different signaling cascades in order to lower blood pressure by inducing the widening and relaxation of blood vessels.

Despite treatment advancements in recent years, some of these medications can cause undesirable side effects, including low blood pressure, heart complications, headache, muscle pain, indigestion, nausea, and other gastrointestinal problems. None of these therapies cures PAH or prevents the disease from progressing over time.

Bioelectronic medicine is an emerging field based on the idea of using special devices to control the electrical activity of the body's nervous system, with the goal of diagnosing and treating certain disorders and injuries.

"Targeting nerves with electrical stimulation to treat diseases has two major advantages over pharmaceutical therapies. First is specificity with regards to the targeted organ system, … [and] second is specificity with regards to time: the timing of delivery of neurostimulation can be tightly controlled," the researchers wrote.

According to the team, a particular type of bioelectronic-based therapy called vagus nerve stimulation (VNS) seems to hold promise for the treatment of PAH.

The vagus nerve is a major nerve that is part of the autonomic nervous system — the non-conscious part of the nervous system that controls several body functions — and is known to control the contraction and relaxation of the heart. For that reason, VNS has been used in the past to treat different types of heart disorders, including arrhythmias, heart failure, and high blood pressure.

VNS may be useful to treat people with PAH because it helps normalize heart function, promotes the widening of blood vessels in the lungs, suppresses inflammation, and restores the balance between the sympathetic and parasympathetic nervous system.

Of note, the sympathetic and parasympathetic nervous system are the two divisions of the autonomic nervous system; the sympathetic system prepares the body for physical and mental activity, while the parasympathetic system is responsible for bodily functions while at rest.

"VNS has proven, positive effects on suppressing inflammation and restoring homeostatic autonomic balance within the body," Stavros Zanos, MD, PhD, assistant professor at the Feinstein Institutes for Medical Research and corresponding author of the study, said in a press release.

"There is a need to explore bioelectronic medicine as a way to normalize the function of the heart and the pulmonary vessels to provide treatment alternatives for PAH and help thousands of patients with this disease," he added.

Preliminary studies in animal models of PAH support the potential therapeutic effects of VNS in PAH. However, further studies are needed to determine "the therapeutic potential of such an approach," the researchers wrote.

  • Author Details
Joana is currently completing her PhD in Biomedicine and Clinical Research at Universidade de Lisboa. She also holds a BSc in Biology and an MSc in Evolutionary and Developmental Biology from Universidade de Lisboa. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that make up the lining of blood vessels — found in the umbilical cord of newborns.
Total Posts: 329
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Joana is currently completing her PhD in Biomedicine and Clinical Research at Universidade de Lisboa. She also holds a BSc in Biology and an MSc in Evolutionary and Developmental Biology from Universidade de Lisboa. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that make up the lining of blood vessels — found in the umbilical cord of newborns.
Latest Posts

Comments

Post a Comment

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Image
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Posted: 11 Jul 2019 12:00 AM PDT For patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction, inhaled epoprostenol through high-flow nasal cannula increases oxygenation, according to a study published in Pharmaceutics . The researchers of this retrospective study assessed the effect of inhaled epoprostenol using a high-flow nasal cannula on oxygenation and future mechanical ventilation in patients with hypoxemia comorbid with pulmonary hypertension or right heart dysfunction in an intensive care unit setting. A chart review was completed on adult patients who were admitted into the respiratory care department of the Rush University Medical Center for severe hypoxemia between July 2015 and April 2018 and treated with inha...
Read more

Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment - my.clevelandclinic.org

Image
Overview Shortness of breath (dyspnea) is most commonly caused by heart or lung conditions. Other causes include anemia, anxiety, lack of exercise or living with obesity. What is dyspnea (shortness of breath)? Dyspnea (pronounced "DISP-nee-uh") is the word healthcare providers use for feeling short of breath. You might describe it as not being able to get enough air ("air hunger"), chest tightness or working harder to breathe. Shortness of breath is often a symptom of heart and lung problems. But it can also be a sign of other conditions like asthma, allergies or anxiety. Intense exercise or having a cold can also make you feel breathless. What are paroxysmal nocturnal dyspnea (PND) and sighing dyspnea? Paroxysmal nocturnal dyspnea (PND) is a feeling like you can't breathe an hour or two after falling asleep. Sighing dyspnea is when you sigh a lot after taking deep breaths in to try to relieve the feeling of dyspnea. What is the differ...
Read more

What to Expect During Pulmonary Embolism Recovery - Healthline

Image
What to Expect During Pulmonary Embolism Recovery - Healthline What to Expect During Pulmonary Embolism Recovery - Healthline Pulmonary Arterial Hypertension: Updates in Epidemiology and Evaluation of Patients - AJMC.com Managed Markets Network Right-Sided Heart Failure: Symptoms, Causes, and Treatments - Healthline Right sided heart failure: Symptoms, outlook, treatment - Medical News Today What to Expect During Pulmonary Embolism Recovery - Healthline Posted: 19 May 2021 12:00 AM PDT A pulmonary embolism (PE) is when a blood clot becomes stuck in the blood vessels of your lung. These clots typically begin in the leg and then break free and travel to the lung. The American Lung Association estimates that about 1 in 1,000 people in the United States experience a PE each year. A PE can be a serious or life threatening condition, which means receiving prompt medical treatment is vital. Treatment of a PE focus...
Read more